Articles Vol. 67 No. 8 28/08/2026

SCOPING REVIEW ON OUTCOMES OF BALLOON SINUPLASTY IN THE TREATMENT OF CHRONIC RHINOSINUSITIS

Nguyen Thi Diep Anh1,2,3,4, Nguyen Quang Trung1,3,5,6, Le ANh Tuan5,6
1 Hanoi Medical University
2 Saint Paul General Hospital
3 Trường Đại học Y Hà Nội
4 Bệnh viện Đa Khoa Xanh Pôn
5 National ENT Hospital
6 Bệnh viên Tai Mũi Họng Trung Ương
DOI: 10.52163/yhc.v67i8.6316
25 Views
0 Downloads
Keywords
Chronic rhinosinusitis, balloon sinuplasty, scoping review.
Abstract

Objective: To study the results of using balloon sinusplasty in the treatment of chronic rhinosinusitis.

 

Subjects and methods: All articles worldwide on the use of balloon sinusplasty in the treatment of chronic rhinosinusitis from 2005 to 2026. Methods: Scoping review using the PRISMA-ScR checklist, updated to April 2026.

Results: Eleven studies involving 695 patients were included. Studies originated from Asia (45.5%), Europe (27.3%), and the Americas (27.3%), predominantly using prospective interventional designs without control groups (36.4%). BSP demonstrated clinically significant symptom improvement, with SNOT-22 score reductions ranging from 17.6 to 43 points and SNOT-20 reductions from 1.57 to 2.5 points. Success rates ranged from 62% to 96.7%. Complications were mostly mild with no serious adverse events reported. Recurrence rates ranged from 1.3% to 22% depending on follow-up duration.

Conclusion: Balloon sinus dilation is an effective and safe method for treating mild to moderate chronic rhinosinusitis and may be considered as an option in some cases before endoscopic sinus surgery

References
[1]
Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. DOI: 10.4193/Rhin20.600 Google Scholar
[2]
Lal D, Hopkins C, Divekar RD. SNOT-22-based clusters in chronic rhinosinusitis without nasal polyposis exhibit distinct endotypic and prognostic differences. Int Forum Allergy Rhinol. 2018;8(7):797-805. DOI: 10.1002/alr.22101 Google Scholar
[3]
Fokkens WJ, De Corso E, Backer V, et al. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024;62(3):287-298. doi:10.4193/Rhin23.415. DOI: 10.4193/Rhin23.415 Google Scholar
[4]
Castro A, Furtado M, Rego Â, Serras D, Plácido M, Martins C. Long term outcomes of balloon sinuplasty for the treatment of chronic rhinosinusitis with and without nasal polyps. Am J Otolaryngol. 2021;42(1):102825. DOI: 10.1016/j.amjoto.2020.102825. Google Scholar
[5]
Cho SH, Kim DW, Gevaert P. Chronic rhinosinusitis without nasal polyps. J Allergy Clin Immunol Pract. 2016;4(4):575-582. DOI: 10.1016/j.jaip.2016.04.015. Google Scholar
[6]
Phương TTM. Nghiên cứu ứng dụng nong lỗ thông các xoang cạnh mũi bằng bộ nong có bóng trong điều trị viêm mũi xoang mạn. Tạp chí Y học Thành phố Hồ Chí Minh. 2014;18(1):39. Google Scholar
[7]
Stankiewicz J, Tami T, Truitt T, Atkins J, Liepert D, Winegar B. Transantral, endoscopically guided balloon dilatation of the ostiomeatal complex for chronic rhinosinusitis under local anesthesia. Am J Rhinol Allergy. 2009;23(3):321-327. DOI: 10.2500/ajra.2009.23.3274. Google Scholar
[8]
Gould J, Alexander I, Tomkin E, Brodner D. In-office, multisinus balloon dilation: 1-year outcomes from a prospective, multicenter, open-label trial. Am J Rhinol Allergy. 2014;28(2):156-163. DOI: 10.2500/ajra.2014.28.4043. Google Scholar